Testing effectiveness (Phase 2)WithdrawnNCT01543750What this trial is testing4-Aminopyridine in Episodic Ataxia Type 2Who this might be right forEpisodic Ataxia Type 2 University of California, Los Angeles
Large-scale testing (Phase 3)Not Yet RecruitingNCT07221292What this trial is testingPivotal Study of N-acetyl-L-leucine for CACNA1AWho this might be right forCACNA1ASpinocerebellar Ataxia Type 6Episodic Ataxia Type 2+1 more IntraBio Inc 60
Not applicableStudy completedNCT05687474What this trial is testingBaby Detect : Genomic Newborn ScreeningWho this might be right forCongenital Adrenal HyperplasiaFamilial Hyperinsulinemic Hypoglycemia 1Phosphoglucomutase 1 Deficiency+121 more Centre Hospitalier Universitaire de Liege 6,824
Not applicableLooking for participantsNCT01793168What this trial is testingRare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at SanfordWho this might be right forRare DisordersUndiagnosed DisordersDisorders of Unknown Prevalence+340 more Sanford Health 20,000
Not applicableStudy completedNCT01470729What this trial is testingBiomarkers in Autosomal Dominant Cerebellar AtaxiaWho this might be right forSpinocerebellar Ataxia Type 1Spinocerebellar Ataxia Type 2Spinocerebellar Ataxia, Autosomal Recessive 3+1 more Assistance Publique - Hôpitaux de Paris 102
Testing effectiveness (Phase 2)Study completedNCT00110045What this trial is testingCaspofungin Acetate in Treating Aspergillosis in Patients With Hematologic Cancer or in Patients Who Have Undergone a Stem Cell TransplantWho this might be right forCancer European Organisation for Research and Treatment of Cancer - EORTC 171